WEBSITE BSE:544355 NSE: JUBLCPL Inc. Year: 2008 Industry: Chemicals My Bucket: Add Stock
Last updated: 15:55
Jubilant Agri & Consumer Products Ltd. (JACPL), established in 2008 and headquartered in Gurugram, Haryana, is a prominent Indian company specializing in a diverse range of products across agriculture, consumer goods, and performance polymers. A wholly owned subsidiary of Jubilant Industries Limited, JACPL operates with a strategic focus on innovation and customer-centric solutions. The company\'s product portfolio encompasses crop nutrition, growth regulators, and protection solutions under the \"Ramban\" brand, positioning it among India\'s t...Read More
Jubilant Agri & Consumer Products Ltd. (JACPL), established in 2008 and headquartered in Gurugram, Haryana, is a prominent Indian company specializing in a diverse range of products across agriculture, consumer goods, and performance polymers. A wholly owned subsidiary of Jubilant Industries Limited, JACPL operates with a strategic focus on innovation and customer-centric solutions. The company\'s product portfolio encompasses crop nutrition, growth regulators, and protection solutions under the \"Ramban\" brand, positioning it among India\'s top producers of Single Super Phosphate (SSP) fertilizers. In the consumer segment, JACPL offers a variety of adhesives, wood finishes, and sealants, with its \"Jivanjor\" brand being a significant player in the Indian market. Additionally, the company is a leading manufacturer of polyvinyl acetate (PVA) and synthetic latex products, serving global markets with applications in industries such as automotive and packaging. JACPL operates five manufacturing facilities across India, located in Gajraula, Kapasan, Nira, Samlaya, and Sahibabad. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹2588 Cr.
Stock P/E 29.3
P/B 5.9
Current Price ₹1708.2
Book Value ₹ 288
Face Value 10
52W High ₹3032
Dividend Yield 0%
52W Low ₹ 1320.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 293 | 300 | 358 | 407 | 398 | 398 | 442 | 513 | 451 |
| Other Income | 0 | 0 | 1 | 0 | 0 | 1 | 2 | 0 | 0 |
| Total Income | 293 | 301 | 359 | 407 | 398 | 399 | 444 | 513 | 451 |
| Total Expenditure | 266 | 278 | 316 | 365 | 363 | 371 | 380 | 449 | 412 |
| Operating Profit | 27 | 22 | 43 | 42 | 35 | 28 | 64 | 64 | 39 |
| Interest | 4 | 5 | 4 | 4 | 3 | 2 | 2 | 1 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Exceptional Income / Expenses | -47 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | -4 |
| Profit Before Tax | -28 | 27 | 35 | 34 | 28 | 21 | 58 | 58 | 29 |
| Provision for Tax | -7 | 5 | 9 | 9 | 6 | 5 | 14 | 16 | 7 |
| Profit After Tax | -21 | 22 | 26 | 25 | 21 | 16 | 44 | 42 | 22 |
| Adjustments | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -21 | 22 | 26 | 25 | 21 | 16 | 44 | 42 | 22 |
| Adjusted Earnings Per Share | -13.9 | 14.5 | 17.1 | 16.4 | 14.2 | 10.6 | 29.3 | 28.1 | 14.2 |
| #(Fig in Cr.) | Mar 2025 | TTM |
|---|---|---|
| Net Sales | 1561 | 1804 |
| Other Income | 2 | 3 |
| Total Income | 1563 | 1807 |
| Total Expenditure | 1414 | 1612 |
| Operating Profit | 149 | 195 |
| Interest | 15 | 7 |
| Depreciation | 16 | 17 |
| Exceptional Income / Expenses | 0 | -4 |
| Profit Before Tax | 118 | 166 |
| Provision for Tax | 30 | 42 |
| Profit After Tax | 88 | 124 |
| Adjustments | -1 | 0 |
| Profit After Adjustments | 88 | 124 |
| Adjusted Earnings Per Share | 58.2 | 82.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 27% | NA% | NA% | NA% |
| ROE Average | 28% | 28% | 28% | 28% |
| ROCE Average | 35% | 35% | 35% | 35% |
| #(Fig in Cr.) | Mar 2025 |
|---|---|
| Shareholder's Funds | 326 |
| Minority's Interest | 0 |
| Borrowings | 3 |
| Other Non-Current Liabilities | 43 |
| Total Current Liabilities | 363 |
| Total Liabilities | 735 |
| Fixed Assets | 180 |
| Other Non-Current Assets | 25 |
| Total Current Assets | 529 |
| Total Assets | 735 |
| #(Fig in Cr.) | Mar 2025 |
|---|---|
| Opening Cash & Cash Equivalents | 15 |
| Cash Flow from Operating Activities | 129 |
| Cash Flow from Investing Activities | -35 |
| Cash Flow from Financing Activities | -104 |
| Net Cash Inflow / Outflow | -9 |
| Closing Cash & Cash Equivalent | 6 |
| # | Mar 2025 |
|---|---|
| Earnings Per Share (Rs) | 58.25 |
| CEPS(Rs) | 69.3 |
| DPS(Rs) | 0 |
| Book NAV/Share(Rs) | 210.72 |
| Core EBITDA Margin(%) | 9.45 |
| EBIT Margin(%) | 8.53 |
| Pre Tax Margin(%) | 7.55 |
| PAT Margin (%) | 5.66 |
| Cash Profit Margin (%) | 6.69 |
| ROA(%) | 12.01 |
| ROE(%) | 27.81 |
| ROCE(%) | 34.93 |
| Receivable days | 67.22 |
| Inventory Days | 44.55 |
| Payable days | 68.57 |
| PER(x) | 21.6 |
| Price/Book(x) | 5.97 |
| Dividend Yield(%) | 0 |
| EV/Net Sales(x) | 1.25 |
| EV/Core EBITDA(x) | 13.03 |
| Net Sales Growth(%) | 0 |
| EBIT Growth(%) | 0 |
| PAT Growth(%) | 0 |
| EPS Growth(%) | 0 |
| Debt/Equity(x) | 0.18 |
| Current Ratio(x) | 1.46 |
| Quick Ratio(x) | 0.93 |
| Interest Cover(x) | 8.74 |
| Total Debt/Mcap(x) | 0.03 |
| # | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 74.78 | 74.78 | 74.78 | 74.78 | 74.37 | 74.36 |
| FII | 0.18 | 0.13 | 0.15 | 0.25 | 0.24 | 0.27 |
| DII | 0.15 | 0.08 | 0.08 | 0.12 | 0.15 | 0.14 |
| Public | 24.89 | 25.01 | 24.99 | 24.85 | 25.24 | 25.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.38 | 0.38 | 0.38 | 0.37 | 0.38 | 0.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.51 | 1.51 | 1.51 | 1.51 | 1.51 | 1.52 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
